Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Resolution Manometry and Neostigmine in SCI Colonic Motility
NCT02574611Phase 1Withdrawn
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Oct 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of neostigmine in Digestive tract dysfunction (4 arms), sponsored by James J. Peters Veterans Affairs Medical Center. Primary endpoint: High Amplitude Propagating Contractions at 2 days. Planned start Oct 2015; status: withdrawn.
02
Drugs
neostigmine
03
Conditions
Digestive tract dysfunction
Beyond the preview
Go deeper on NCT02574611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574611.